en-clofert 50 (Androxal), in development by Repros Therapeutics Inc, is a non-
steroidal estrogen receptor antagonist that promotes gonadotropin-dependent
testosterone secretion by the testes.
Enclomiphene 50 constitutes the trans-stereoisomer of clomiphene citrate, a
drug that has been widely prescribed for several decades for the treatment of
female ovulatory dysfunction.
Artesunate 50 is a water-soluble hemisuccinate derivative of artemisinin. It is unpredictable in neutral remedy as well as the injectable formulation must be
prepared right away prior to use in 5% (w/v) sodium bicarbonate option to produce
the salt sodium artesunate.